TxCell snaps up option to in-license CAR-Treg programme
TxCell has announced that it has exercised its option to in-license a HLA-A2 CAR-Treg programme from its partner, the University of British Columbia.
Archives for July 10, 2018
Scientists convert skin cells to stem cells via CRISPRa, an industry first
Researchers have, for the first time, managed to successfully convert human skin cells into pluripotent stem cells by altering the cell’s own genes.
EMA backs first CAR T-cell therapies for approval in ‘watershed moment,’ says Novartis
The EMA has recommended approval of Novartis’ Kymriah and Kite Pharma’s Yescarta – a first for personalised gene modified cell therapies in Europe.